T1	p 32 41	anxiety :
T2	p 248 274	92 outpatients affected by
T3	p 287 311	anxiety disorders for at
T4	p 374 401	47 patients were randomized
T5	p 594 596	at
T6	p 806 822	with the Italian
T7	p 829 834	scale
T8	p 888 924	Seventy-eight patients completed the
T9	p 1475 1495	responder patients (
T10	p 1583 1592	withdrawn
T11	p 1635 1636	.
T12	i 19 28	ketazolam
T13	i 59 77	placebo-controlled
T14	i 162 171	ketazolam
T15	i 187 203	) with placebo ,
T16	i 405 417	ketazolam 15
T17	i 433 440	placebo
T18	i 589 590	)
T19	i 701 710	ketazolam
T20	i 1148 1155	placebo
T21	i 1565 1572	placebo
T22	o 19 28	ketazolam
T23	o 32 39	anxiety
T24	o 295 304	disorders
T25	o 545 588	total Hamilton Anxiety Rating Scale ( HAM-A
T26	o 617 622	value
T27	o 768 775	Anxiety
T28	o 823 834	HAM-A scale
T29	o 854 869	scale ( patient
T30	o 1002 1015	of responders
T31	o 1179 1190	HAM-A score
T32	o 1392 1405	4-point scale
T33	o 1516 1530	. Tolerability
T34	o 1626 1636	headache .